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Sepsis is a life-threatening condition caused by a dysregulated host response to
infection. Endothelial cells (EC) are actively involved in sepsis-associated (micro)vascular
disturbances and subsequent organ dysfunction. Lipopolysaccharide (LPS), a
Gram-negative bacterial product, can activate EC leading to the expression of
pro-inflammatory molecules. This process is molecularly regulated by specific receptors
and distinct, yet poorly understood intracellular signaling pathways. LPS-induced
expression of endothelial adhesion molecules E-selectin and VCAM-1 in mice was
previously shown to be organ- andmicrovascular-specific. Here we report that also within
renal microvascular beds the endothelium expresses different extents of E-selectin and
VCAM-1. This heterogeneity was recapitulated in vitro in LPS-activated human umbilical
vein EC (HUVEC). Within 2 h after LPS exposure, four distinct HUVEC subpopulations
were visible by flow cytometric analysis detecting E-selectin and VCAM-1 protein.
These encompassed E-selectin−/VCAM-1− (–/–), E-selectin+/VCAM-1− (E-sel+),
E-selectin+/VCAM-1+ (+/+), and E-selectin−/VCAM-1+ (VCAM-1+) subpopulations.
The formation of subpopulations was a common response of endothelial cells to LPS
challenge. Using fluorescence-activated cell sorting (FACS) we demonstrated that the
+/+ subpopulation also expressed the highest levels of inflammatory cytokines and
chemokines. The differences in responsiveness of EC subpopulations could not be
explained by differential expression of LPS receptors TLR4 and RIG-I. Functional studies,
however, demonstrated that the formation of the E-sel+ subpopulation was mainly
TLR4-mediated, while the formation of the +/+ subpopulation was mediated by both
TLR4 and RIG-I. Pharmacological blockade of NF-κB and p38 MAPK furthermore
revealed a prominent role of their signaling cascades in E-sel+ and +/+ subpopulation
formation. In contrast, the VCAM-1+ subpopulation was not controlled by any of these
signaling pathways. Noteworthy is the existence of a “quiescent” subpopulation that was
devoid of the two adhesion molecules and did not express cytokines or chemokines
despite LPS exposure. Summarizing, our findings suggest that LPS activates different
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signaling mechanisms in EC that drive heterogeneous expression of EC inflammatory
molecules. Further characterization of the signaling pathways involved will enhance our
understanding of endothelial heterogeneous responses to sepsis related stimuli and
enable the future design of effective therapeutic strategies to interfere in these processes
to counteract sepsis-associated organ dysfunction.
Keywords: endothelial cells, HUVEC, lipopolysaccharide (LPS), adhesion molecules, endothelial heterogeneity,
intracellular signaling
INTRODUCTION
Sepsis is defined as a life-threatening organ dysfunction caused by
a dysregulated host response to infection (1). Despite diagnostic
advances in early recognition, sepsis often escalates to multiple
organ dysfunction syndrome (MODS), leading to poor outcome.
Sepsis affects around 30 million people yearly worldwide,
resulting in 6 million deaths (2). Although several mechanisms
have been suggested to contribute to the pathophysiology of
sepsis, it is still incompletely understood, thereby hindering the
development of successful treatment options for patients with
sepsis and sepsis-induced multiple organ dysfunction syndrome.
Endothelial cells (EC) line all blood vessels and are one
of the first cells to respond to microbial product such
as Lipopolysaccharide (LPS) (3). During sepsis, EC respond
to LPS via the activation of pattern recognition receptors
(PRRs), producing pro-inflammatory cytokines, chemokines,
and adhesion molecules (4). Adhesion molecules such as E-
selectin, VCAM-1, and ICAM-1 facilitate endothelial cell—
leukocyte interactions, resulting in leukocyte recruitment into
inflamed tissues leading to subsequent impairment of organ
function (5). Therapeutic strategies designed to attenuate EC
production of these inflammation associated molecules to
prevent leukocyte adhesion and transmigration, may lead to
diminished organ failure in patients with sepsis.
Previous studies from our laboratory have shown that in
mice, LPS or TNF-α exposure results in organ and microvascular
compartment specific expression of adhesion molecules (6–8).
Within the kidney, at the microvascular compartment level,
TNF-α induced expression of E-selectin is abundant in glomeruli,
but low in the arterioles. In contrast, VCAM-1 is highly expressed
in the arterioles, while expressed to a lesser extent in the glomeruli
(6, 7). Our knowledge on inter- and intra-organ endothelial
heterogeneity has expanded in recent years, yet how these
heterogeneous responses are molecularly controlled following
LPS challenge still remains elusive.
Toll-Like Receptor 4 (TLR4) (9) and the more recently
identified retinoic acid inducible gene-I (RIG-I) (10) are
pattern recognition receptors which have been shown to drive
endothelial responses to LPS. The recognition of LPS via
these receptors results in the induction of endothelial adhesion
molecules, cytokines, and chemokines via several downstream
signaling pathways, that include NF-κB (10–12), and p38 MAPK
(12, 13). Although both NF-κB and p38 MAPK have been
implicated in controlling LPS-mediated inflammatory responses,
it is unknown whether one, the other, both, or other signaling
pathways regulate individual EC responses at a cellular level.
Likewise, and of interest in relation to the microvascular
compartment specific responses of the endothelium to LPS
challenge in vivo, whether all EC are equipped with similar
downstream signaling machinery remains to be elucidated.
Here, we investigate the molecular control of the early stages
of EC activation by LPS in relation to the previously reported
heterogeneous EC responses found in vivo. We focused on LPS
induced expression patterns of E-selectin and VCAM-1 within
mouse renal microvascular compartments in vivo and their
patterns in HUVEC in vitro using immunofluorescent staining
and flow cytometry, respectively. Based on the outcome we next
investigated in vitro whether different stages of cell division
could explain the observed heterogeneous subpopulations
formed, and whether these subpopulations behaved differently
because of differential expression of LPS signaling machinery
components. Additionally, we used pharmacological tools to
examine the activity of different kinase signaling pathways




Male C57BL/6 mice purchased from Envigo (Horst, The
Netherlands) and housed in a specific pathogen-free facility,
maintained on chow and water ad libitum, and housed in
temperature-controlled chambers (24◦C) with a 12 h light/dark
cycle. Mice were challenged with intraperitoneal (i.p) injection
of 1 mg/kg LPS [E. coli, serotype O26:B6 (15,000 EU/g), Sigma-
Aldrich, St. Louis, MO, USA] as described elsewhere (14).
Control mice were i.p administered with the same volume of
0.9% NaCl. Mice were terminated under isoflurane anesthesia
4 h after LPS challenge. Blood was subsequently drawn via
cardiac puncture and the organs harvested, snap-frozen on
liquid nitrogen and stored at −80◦C until further analysis. All
experiments were performed in compliance with the animal
ethics committee of the University of Groningen.
Endothelial Cell Culture and Stimulation
Human umbilical vein endothelial cells (HUVEC) and human
lung microvascular endothelial cells (HMVEC-L) were
purchased from Lonza (Lonza, Breda, the Netherlands) and
cultured in EBM-2 medium supplemented with EGM-2MV
Single Quot Kit Supplements and Growth factors (Lonza)
at 37◦C with 5% CO2/95% air conditions until passage 5 at
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the UMCG Endothelial Cell Facility. Additionally, HUVEC
were isolated from umbilical cords and cultured on 1% gelatin
coated plates with RPMI 1640 medium (Lonza) supplemented
with 20% heat inactivated FCS, 2mM L-glutamine, 5 U/ml
heparin, 50µg/ml endothelial growth factor, and antibiotics
(100IE/penicillin and 50µg/ml streptomycin). HUVEC and
HMVEC-L were seeded in 6 or 12 well plates. HUVEC were
70% confluent on the day of siRNA transfection while they
were confluent when treated with LPS (E. coli, serotype O26:B6;
E. coli, serotype O111:B4, Sigma Aldrich, St. Louis, MO) at
1µg/mL for 4 h unless indicated otherwise.
Cryosection Immunofluorescence Staining
Five-micrometer cryosections from snap-frozen mouse kidneys
were fixed in acetone for 10min. The sections were blocked with
0.00125% H202 (Merck, Darmstadt, Germany) in demineralized
H20 for 10min, and subsequently blocked with 3% bovine
serum albumin (BSA) in phosphate buffered saline (PBS)
(w/v) for 30min. Kidney sections were incubated at room
temperature (RT) for 1 h with primary rat-anti-mouse E-selectin
antibody (10µg/mL, clone MES-1, kindly provided by Dr. D
Brown, UCB Celltech, Brussels, Belgium) diluted in 5% fetal
calf serum (FCS) (Sigma, St. Louis, Missouri, USA) in PBS.
After washing, sections were incubated with rabbit anti-rat
IgG (Vector Laboratories Inc, Burlingame, CA, USA) in 1%
normal mouse serum (NMS) (Sanquin, Amsterdam, NL)/5%
FCS in PBS for 45min. The sections were then washed and
incubated with anti-rabbit HRP polymer (Dako, Carpentaria,
CA, USA) for 30min. After washing, the sections were exposed
to Alexa Fluor R©555 Tyramide reagent prepared according
to the manufacturer’s instructions (#B40955, Thermo Fisher
Scientific, Carlsbad, CA, USA). For the sequential second
primary antibody incubation, the sections were washed and
blocked again with 3% (w/v) BSA in PBS for 30min. The
second primary antibody, rat anti-mouse VCAM-1 (hybridoma
supernatant of clone M/K-1.9, ATCC, Manassas VA, USA)
was added to the sections for 1 h at RT. After washing, the
sections were incubated with 20µg/mL of goat anti-rat antibody
conjugated with Alexa Fluor R©488 (Thermo Fisher Scientific)
/ DAPI (1.5µg/mL; Thermo Fisher Scientific) in 5% FCS in
PBS for 45min, washed, and mounted with Aqua/polymount
(Polysciences Inc, Warrington, PA, USA). Isotype controls
included rat IgG2a and rat IgG1 (10µg/mL; both from Antigenix
America Inc., Huntington Station, NY, USA). Images were taken
using a Leica SP8 confocal laser scanning microscope (Leica
Microsystems Ltd., Germany) with objective and numerical
apertures of 40X and 1.3, respectively. Image cubes were
recorded with appropriate filters using Leica application suite
X software. Peak emission for Alexa Fluor 488 (VCAM-1) was
at 550 nm and for Alexa Fluor 555 (E-selectin) at 610 nm.
All images were captured with equal exposure times and then
analyzed using Imaris image analysis software (Bitplane AG,
Zurich, Switzerland).
For CD31/E-selectin respectively CD31/VCAM-1 double
staining, the kidney cryosections were blocked with peroxidase
and 3% BSA as described above, incubated with rat-anti mouse
CD31 antibody (0.15µg/mL, # 550274 BD Pharmingen, Franklin
Lakes, NJ, USA) diluted in 5% FCS in PBS for 1 h, and
subsequently stained with rat anti-mouse antibody E-selectin,
or rat anti-mouse VCAM-1 according to the above-described
protocols. The images were taken with a Leica DM4000B
fluorescence microscope equipped with a Leica DFC345FX
digital camera (Leica Microsystems Ltd., Germany) and Leica
LAS V4.5 Image Software at 100X magnification with equal
exposure times.
Flow Cytometry
We employed flow cytometry to determine the expression of
endothelial adhesion molecules. HUVEC or HMVEC-L were
briefly washed with sterile PBS, trypsinized with trypsin-EDTA
(0.025%) and washed with ice-cold wash buffer (5% FCS in
PBS). Cells were then transferred to FACS tubes, washed and
resuspended in 3% v/v PE-conjugated mouse anti-human E-
selectin (Cat. No #322606, BioLegend, San Diego, CA, USA)
and APC-conjugated mouse anti-human VCAM-1 (Cat. No
#305810, BioLegend) antibodies in wash buffer for 30min on
ice in the dark. For intracellular staining, HUVEC were fixed
with Fixation Reagent A (#GAS004, Thermo Fisher Scientific) for
15min, washed, and subsequently incubated with perm buffer
Reagent B (Thermo Fisher Scientific) and 3% (v/v) Brilliant
Violet 421-conjugated anti-Ki67 (#330505, Biolegend, San Diego,
CA, USA) antibody in wash buffer for 30min, on ice in the
dark. The cells were then washed and resuspended in wash buffer
and analyzed using a MACSQuant Analyzer 10 flow cytometer
(Miltenyi Biotech, San Diego, CA, USA). Data analysis was
performed using Kaluza Flow analysis software (v.2.1) (Beckman
Coulter, Brea, CA, USA) or FlowJo software (v.10) (Ashland,
OR, USA). Isotype control antibodies mouse IgG1κ-BV421
(Cat No #400157, Biolegend), IgG2aκ-PE (Cat No #2-4724-42,
eBioscience, San Diego, CA, USA), and mouse IgG1 (Cat No
# IC002A, R&D System, Minneapolis, MN, USA) were used to
correct for signals from non-specific binding.
Fluorescence-Activated Cell
Sorting (FACS)
HUVEC treated with LPS for 4 h were trypsinized, washed and
subsequently incubated with PE-conjugated mouse anti-human
E-selectin and APC-conjugated mouse anti-human VCAM-1
antibodies as described above. After the staining procedure,
the cells were sorted into 4 subpopulations based on the
staining pattern of E-selectin and VCAM-1 using a MoFlo
Astrios FACS machine (Beckman Coulter, Brea, CA, USA):
“quiescent” E-sel−/VCAM-1− (-/-), E-sel+/VCAM−1- (E-sel+),
E-sel+/VCAM-1+ (+/+), and E-sel−/VCAM-1+ (VCAM-1+)
subpopulations (see Figure 4A). After sorting, the purity of each
collected population of cells was verified by flow cytometry before
subsequent analyses were performed (data not shown).
Trypsinization per se did not alter detection of membrane
expression of the adhesion molecules in flow cytometry, as
detachment of endothelial cells with versene, a gentle non-
enzymatic cell dissociation reagent, showed similar patterns of
endothelial surface protein expression (data not shown).
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Gene Expression Analysis by RT-qPCR
Total RNA from the cells was isolated using the RNeasy R©
mini kit (Qiagen, Venlo, The Netherlands) according to the
manufacturer’s protocols. RNA concentration (OD 260) and
purity (OD260/OD280) was determined using a NanoDrop R©
ND-1000 UV-Vis spectrophotometer (NanoDrop Technologies,
Rockland, ME, USA). Samples with an OD260/OD280 ratio
of ≥1.8 were included in the analysis. cDNA synthesis
was performed as previously described (15). Quantitative
(q)PCR was performed in a ViiA 7 PCR System (Applied
Biosystems Nieuwerkerk aan den IJssel, The Netherlands)
using the following assay-on-Demand primers (Applied
Biosystems,): GAPDH (assay ID Hs99999905_m1), E-
selectin (assay ID Hs00174057_m1), VCAM-1 (assay ID
Hs00365486_m1), TLR4 (assay ID Hs00152939_m1), RIG-I
(assay ID Hs00204833_m1), MAVS (assay ID Hs00920075), IL-6
(assay ID Hs00174131_m1), IL-8 (assay ID Hs00174103_m1),
MCP-1 (assay ID Hs00234140_m1), CXCL10 (assay ID
Hs01124251_g1), and CXCL6 (assay ID Hs00605742_g1).
Duplicate analyses were performed for each sample and the
obtained threshold cycle values (CT) averaged. All genes were
normalized to the expression of housekeeping gene GAPDH,
yielding the 1CT value. The relative mRNA level was calculated
by 2−1CT.
siRNA–Mediated Gene Silencing
TLR4, RIG-I, and MAVS were knocked down in HUVEC
using FlexiTube siRNA (Qiagen). AllStars negative control
siRNA (Qiagen) was used as a negative control for all RNA
interference experiments. Transient transfection was performed
using Lipofectamine 2000 (Life Technologies, Carlsbad, CA,
USA) according to the manufacturer’s instructions. Knockdown
of these genes did not diminish endothelial cell viability as
described previously (10).
Pharmacological Inhibition of Signaling
Pathways
BAY11-7082 (BAY) (Alexis Biochemicals, San Diego, CA, USA)
was dissolved in DMSO as a 20mM stock solution, while
LY2228820 (LY) (MedChemExpress, Monmouth Junction, NJ,
USA) was dissolved in DMSO as a 10mM stock solution
according to manufacturers’ instructions. Stocks were stored at
−80◦C until needed. Prior to the experiment, BAY and LY stock
solutions were diluted inHUVEC culturemedium. HUVECwere
pre-treated with 10µM of BAY 30min before, and/or 10µM of
LY 1 h before LPS stimulation. The viability and morphology
of HUVEC were assessed microscopically before and after pre-
treatment with either BAY or LY, and they were found to be of
normal cobble-stone morphology throughout the experiments.
Statistical Analysis
Statistical analysis of results was performed by two-tailed
unpaired Student t-test, or one-way ANOVA followed by
Bonferroni post hoc analysis to comparemultiple replicatemeans.
All statistical data were analyzed using GraphPad Prism software
v.7 (GraphPad Prism Software Inc., San Diego, CA, USA).
Differences were considered significant when p< 0.05.
RESULTS
Distinct Expression Patterns of E-Selectin
and VCAM-1 Are Found Within Kidney
Microvascular Compartments of
LPS-Treated Mice
Heterogeneous expression of E-selectin and VCAM-1 between
different renal microvascular compartments has been previously
reported. Intravascular heterogeneity in expression of endothelial
adhesion molecules within specific renal microvascular beds,
on the other hand, is not extensively described. To investigate
the expression patterns of E-selectin and VCAM-1 in the
different kidney microvascular segments, we performed
immunofluorescent double staining to detect these two adhesion
molecules at the same time. In control kidney, E-selectin
protein was absent from all microvascular compartments,
while arterioles expressed basal VCAM-1 protein Figure 1,
confirming previous data from our laboratory (7, 16). Following
LPS challenge, E-selectin and VCAM-1 became visible in
all kidney microvascular segments. However, E-selectin was
mainly expressed in the glomeruli, whereas the arterioles
predominantly expressed VCAM-1, with scattered co-expression
of E-selectin. The peritubular capillaries and post-capillary
venules mainly co-expressed E-selectin and VCAM-1, while
occasional single E-selectin or VCAM-1 positive cells were found
Figure 1. Double immunostaining of CD31, a pan-endothelial
marker and E-selectin respectively VCAM-1 confirmed their
expression by endothelial cells in the microvascular segments
(Supplementary Figure 1). These data demonstrate that EC in
different microvascular compartments, and also within the same
microvascular compartment, exert a heterogeneous phenotype
which can be identified by different patterns of E-selectin and
VCAM-1 protein expression following LPS challenge.
LPS Stimulation of Endothelial Cells in
vitro Uncover Cell Subpopulations Based
on E-Selectin and VCAM-1 Expression
To investigate whether EC in vitro can also express E-selectin
and VCAM-1 in varying patterns, we stimulated HUVEC
with 1µg/mL LPS for 4 h, after which we flow cytometrically
determined E-selectin and VCAM-1 protein levels. In control
cells, E-selectin and VCAM-1 expression levels were low
(Figure 2A). After 4 h of LPS stimulation, the expression of
both E-selectin and VCAM-1 was increased, as evidenced by
the shift in the Mean Fluorescent Intensity (MFI) relative to
non-stimulated controls (Figure 2A). At the cell population
level, 4 h of LPS exposure surprisingly revealed the formation
of EC subpopulations Figure 2B; Supplementary Figure 2A
which bear similarities with the subpopulations observed in the
microvasculature in the kidney. A large subpopulation of EC
(approximately 50%) expressed both E-selectin and VCAM-1,
while at the same time a significant subset of cells (approximately
20%) remained “quiescent” despite exposure to LPS Figure 2B;
Supplementary Figure 2A. Moreover, two additional EC
subpopulations were identified that expressed either E-selectin
or VCAM-1 Figure 2B; Supplementary Figure 2A. Similar
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FIGURE 1 | Distinct expression patterns of E-selectin and VCAM-1 are found within kidney microvascular compartments of LPS-treated mice. E-selectin and VCAM-1
expression varied between and within the renal microvascular segments of LPS-treated mice. The images show immunofluorescence staining of E-selectin (red),
VCAM-1 (green), and DAPI nuclear staining (blue) in the kidney of control mice (vehicle treated) and mice challenged with LPS (1 mg/kg, i.p.) and sacrificed 4 h later. All
images were captured with equal exposure times. Original magnification x400.
results were found when exposing HUVEC isolated from
single donors to 4 h LPS (Figure 2B), and also human lung
microvascular endothelial cells (HMVEC-L) exposed to LPS
revealed the formation of these four subpopulations Figure 2B.
Endothelial subpopulations identified by heterogeneous
expression of E-selectin and VCAM-1 and combinations thereof
after LPS exposure is therefore not restricted to HUVEC and not
donor related but a common response of endothelial cells.
We next studied the kinetics of E-selectin and VCAM-
1 expression in HUVEC. Upon LPS exposure, some EC
started to express E-selectin as early as 1 h after start of
activation by LPS, while at 2 h, VCAM-1 expression became
apparent Figure 2C; Supplementary Figure 2B. Moreover, at
this early timepoint, four EC subpopulations already had
started to form, i.c., “quiescent” E-selectin−/VCAM-1− (-/-),
E-selectin+/VCAM-1− (E-sel+), E-selectin+/VCAM-1+ (+/+),
and E-selectin−/VCAM-1+ (VCAM-1+). These expression
profiles were retained until 6 h of LPS exposure, after which
the E-selectin positive subpopulation diminished in cell number,
while the VCAM-1+ subset and quiescent subpopulations
increased. At 24 h, most EC had returned to a quiescent
state, with only a small VCAM-1+ subset (7% of all cells)
still being present (Figure 2C). A quiescent endothelial cell
subpopulation was constantly present at all times Figure 2C;
Supplementary Figure 2B. Furthermore, these patterns of E-
selectin and VCAM-1 expression were similar when exposed
to different LPS concentrations, except for the lowest LPS
concentration (0.1µg/mL) which did not seem to activate the
endothelial cells (Supplementary Figure 2C). Taken together,
our data demonstrate that activation of endothelial cells by LPS
leads to E-selectin and VCAM-1 (co)expression patterns that
are dynamically changing depending on the time of exposure
to LPS and which are not affected by the concentration of
LPS used.
Cell Division Is Not a Major Factor in
Controlling the Ability of EC to Express
E-Selectin and/or VCAM-1 When Exposed
to LPS
HeLa cells were reported to repress NF-κB activity following
inflammatory stimulation while dividing as cell division appeared
to have a higher cellular priority (17). Whether this also occurs in
dividing endothelial cells is currently unknown.We hypothesized
that the quiescent EC subpopulation was unable to express E-
selectin and VCAM-1 because these cells are actively dividing.
Staining for Ki67, a marker of actively dividing cells, however,
revealed that the total number of Ki67 cells in the HUVEC
population as a whole was only approximately 7% Figure 3. This
is much less than the 25% of cells in the quiescent cell population
after LPS stimulation. Moreover, when gating the Ki67 positive
cells we found that they were present in all four flow cytometric
quadrants Figure 3. Hence, cell division per se does not seem
to be a major factor influencing the ability of EC to express
E-selectin and/or VCAM-1 and is therefore not a likely factor
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FIGURE 2 | LPS stimulation of endothelial cells in vitro induces the formation of EC subpopulations based on E-selectin and VCAM-1 expression. (A) Histograms of
HUVEC as one whole population show the mean fluorescent intensity (MFI) of E-selectin and VCAM-1 in untreated control and EC treated with LPS for 4 h. Isotype
controls were also included. (B) Scatterplots of EC subpopulations based on E-selectin and VCAM-1 expression in multi-donor HUVEC, single donor HUVEC, and
lung microvascular endothelium (HMVEC-L), 4 h after LPS exposure. The data shown is representative of at least four independent experiments. (C) Kinetics of EC
subpopulation formation based on E-selectin and VCAM-1 expression in HUVEC stimulated with LPS for the indicated time periods. The data shown is representative
of two independent experiments.
contributing to the “quiescence status” of EC that do not express
the adhesion molecules upon exposure to LPS.
Endothelial Subpopulations Have Distinct
mRNA Expression Levels of LPS Signaling
Pathway Components and
Inflammatory Genes
LPS induced adhesion molecule expression in EC is known to be
mediated by at least two pattern recognition receptors, TLR4 and
RIG-I (10, 18).We therefore hypothesized that the subpopulation
distribution of EC after LPS exposure identified by E-selectin
and VCAM-1 patterns was due to different subpopulations
expressing LPS signaling components to different extents. To
investigate this, we incubated HUVEC with LPS for 4 h and
then separated the quiescent -/-, E-sel+, +/+ and VCAM-1+
subpopulations by fluorescence activated cell sorting (FACS).
After sorting and confirmation of subpopulation purity (data
not shown), we first determined the E-selectin and VCAM-
1 mRNA expression levels Figure 4B. E-selectin and VCAM-
1 mRNA levels were close to absent in the quiescent -/-
subpopulation, while E-selectin mRNA was high in E-sel+ and
+/+ subpopulations, and VCAM-1 mRNA was high in+/+ and
VCAM-1+ subpopulations thereby corroborating the protein
data. We proceeded to determine the mRNA expression levels
of TLR4 and RIG-I within the different EC subpopulations.
TLR4 mRNA levels were similar in all EC subpopulations
including the quiescent one Figure 4B. RIG-I mRNA levels
were highest in the E-sel+/VCAM-1+ cell population and
expressed at a slightly lower level in the other EC subpopulations
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FIGURE 3 | Cell division is not a major factor controlling the ability of EC to express E-selectin and/or VCAM-1 when exposed to LPS. HUVEC exposed to LPS for 4 h
were stained for Ki67 after which Ki67 positive cells were gated and the extent of E-selectin and VCAM-1 expression on those cells determined. Ki67 positive cells are
indicated in red. The percentage of Ki67 positive cells expressing different extents of E-selectin and VCAM-1 is reported as the mean ± SD of three independent
experiments.
Figure 4B, while mRNA levels of MAVS, a downstream protein
adaptor of RIG-I, were similar in all four EC subpopulations
Figure 4B. To further investigate the inflammatory status of
the four subpopulations, we analyzed the expression levels of
a series of cytokines/chemokines known to be produced by
endothelial cells in inflammatory conditions. While both the
quiescent and the VCAM-1+ subpopulations expressed the
lowest levels of these genes, the +/+ subpopulation exerted
the most pronounced inflammatory phenotype Figure 4C.
These results demonstrate that upon LPS exposure, there are
distinct endothelial subpopulations with varying LPS signaling
components and inflammatory phenotypes within a HUVEC
cell population.
TLR4 and RIG-I Differentially Regulate
LPS-Mediated E-Selectin/VCAM-1
Expressing Subpopulations
Since both receptors are expressed in all EC subpopulations,
we proceeded to examine the effect of TLR4 and RIG-
I siRNA knockdown on the formation of E-selectin and
VCAM-1 expressing subpopulations in HUVEC upon LPS
exposure. Knockdown of both TLR4 and RIG-I resulted in
diminished protein levels of both E-selectin and VCAM-1
when analyzing the HUVEC population as a whole (data not
shown) corroborating previous findings (10). While only TLR4
knockdown resulted in inhibition of the E-sel+ subpopulation
formation, knockdown of either TLR4 or RIG-I resulted in a
major inhibition of +/+ subpopulation formation Figure 5A.
As a consequence, the -/- “quiescent” subpopulation increased
Figure 5A. In contrast to the inhibitory effect observed on the
E-sel+ or +/+ subpopulations, knockdown of TLR4 or RIG-
I did not inhibit the VCAM-1+ subpopulation from forming
Figure 5A. Similar to the effects of RIG-I knockdown, MAVS
knockdown inhibited the formation of the +/+ subpopulation
with no effect on E-sel+ or VCAM-1+ subpopulation formation
Figure 5B. These results suggest that TLR4 predominantly
controls the formation of E-sel+ cells and that both TLR4
and RIG-I control the formation of the E-sel+/VCAM-
1+ population.
LPS-Mediated E-Selectin/VCAM-1
Expressing HUVEC Subpopulations Are
Regulated by Different Downstream
Signaling Mechanisms
We previously found that the absence of RIG-I or MAVS
inhibited nuclear translocation of the NF-κB p65 subunit
(10). Moreover, the NF-κB p65 subunit translocated from
the cytoplasm to the nucleus in only 26% of EC 30min
after LPS stimulation (Supplementary Figure 3). Apart from
NF-κB signaling, activation of p38 MAPK signaling in LPS
exposed endothelial cells has previously been reported (19, 20).
We therefore investigated whether one or both of these two
signaling pathways were affecting the formation of one or more
subpopulations employing pharmacological tools and if so, to
what extent the subpopulations were affected.
When examining the subpopulation distribution after 2 h
exposure to LPS we found that p38 MAPK inhibition using
LY exerted a major inhibitory effect on the formation of the
E-sel+ subpopulation Figure 6A. In contrast, NF-κB inhibition
using BAY did not significantly influence the formation of any
of the subpopulations at this early time point. At 4 h LPS
exposure however, blockade of NF-κB and p38 MAPK had
inhibited the formation of the +/+ subpopulation (Figure 6B).
In addition, the combination of NF-κB and p38MAPK inhibition
strongly diminished the formation of the E-selectin+/VCAM-
1+ expressing subpopulation Figure 6B. Formation of the
VCAM-1+ subpopulation was not affected by inhibition of
NF-κB and/or p38 MAPK. Also, inhibition of both NF-
κB and p38 MAPK did not fully block the formation of
the subpopulations, suggesting that other signaling pathways
contribute to their formation.
DISCUSSION
Sepsis is a life-threatening condition which is characterized by
progressive host dysregulation, following a known or suspected
infection (1). Sepsis pathophysiology is still not fully understood
which has hampered the development of therapeutic options
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FIGURE 4 | Endothelial subpopulations have distinct mRNA expression levels of LPS signaling pathway components and inflammatory genes. (A) Experimental
design for EC sorting using FACS. (B) mRNA expression levels of E-selectin, VCAM-1, TLR4, RIG-I, and MAVS in sorted EC subpopulations as determined by
RT-qPCR using GAPDH as the housekeeping gene. Bars represent the mean ± SD of 5 independent experiments. p < 0.05 is considered statistically significant.
(C) Heatmap displaying pro-inflammatory adhesion molecule, cytokine, and chemokine mRNA levels in sorted EC subpopulations compared to unsorted LPS control
EC. The data shown is from four independent experiments.
counteracting organ failure in patients with sepsis. Due to their
location, endothelial cells are among the first cells to respond
to systemic pathogens or bacterial products (3). A hallmark of
sepsis-related organ dysfunction is (micro)vascular dysfunction
which include endothelial activation. This results in immune
cell infiltration which can be detrimental for organ function
(5). The current study aimed to explore the molecular control
of early LPS mediated endothelial activation in relation to
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FIGURE 5 | TLR4 and RIG-I-MAVS differentially regulate LPS-mediated
E-selectin/VCAM-1 subpopulation formation. (A) The effect of small interfering
RNA (siRNA)-based RIG-I and TLR4 knockdown on the formation of
LPS-induced EC subpopulations based on E-selectin and VCAM-1 expression
after 4 h of LPS exposure compared to scramble siRNA (siScr) controls. Bars
represent the mean ± SD of 4 independent experiments. (B) The
consequence of MAVS knockdown on the formation of the EC
subpopulations. Bars represent the mean ± SD of 3 independent
experiments. p < 0.05 is considered statistically significant.
previously reported heterogeneous EC responses found in vivo.
Our findings reveal that in the kidneys of mice challenged with
LPS, EC between different microvascular compartments and
also within the same microvascular bed, exert a heterogeneous
phenotype as identified by different patterns of E-selectin and
VCAM-1 protein expression. Moreover, we observed that in
vitro in endothelial cell cultures, subpopulations appear shortly
after the start of LPS exposure that exert a phenotypic E-
selectin/VCAM-1 heterogeneity similar to that observed in the
mouse kidney. These endothelial subpopulations have distinct
inflammatory phenotypes, with the E-selectin/VCAM-1 double
positive subset showing the highest level of activation. The
formation of the subpopulations is differentially regulated by
distinct signaling mechanisms, both at the level of TLR4
and RIG-I, and at the level of the NF-κB and p38 MAPK
pathways. Strikingly, we found a quiescent population of
cells that was not only devoid of E-selectin and VCAM-
1 expression but was also lacking the expression of other
proinflammatory cytokines and chemokines despite exposure
to LPS.
It is well known that EC acquire organ- and tissue-specific
identities to support the unique requirements of various organs
in the body (21). The differential expression of E-selectin and
VCAM-1 in different renal microvascular compartments of
LPS-treated mice reported in this study corroborates previous
observations from our group (6, 7). In addition, we revealed that
FIGURE 6 | LPS-mediated E-selectin/VCAM-1 HUVEC subpopulations are
regulated by different downstream signaling mechanisms. (A) The effect of
pharmacologically inhibiting NF-κB with BAY 11-7082 (BAY) and p38 MAPK
with LY2228820 (LY) pre-treatment on the formation of the LPS-induced EC
subpopulations based on E-selectin and VCAM-1 expression, after 2 h of LPS
exposure; and (B) after 4 h of LPS exposure. Bars represent the mean ± SD of
4 independent experiments. p < 0.05 is considered statistically significant.
within the same microvascular compartment, endothelial cells
heterogenically express E-selectin and VCAM-1 following LPS
challenge. While phenotypic differences between adjacent EC
conditioned in the same environment were previously shown for
endothelial barrier antigen in capillaries of the brain of rats (22)
and for Tie-2 in mouse xenografts associated tumor neovessels
(23), heterogeneous expression of cell adhesion molecules within
individual microvascular segments has to our knowledge not
been reported before. Interestingly, endothelial cells in vitro
exhibited a similar phenotypic heterogeneity in E-selectin and
VCAM-1 (co)expression patterns. The four subpopulations of
EC, each with a different composition of E-selectin / VCAM-1
(co)expression, did not only appear in multi-donor HUVEC, but
also in single-donor HUVEC and in human lung microvascular
endothelial cells (HMVEC-L) exposed to LPS. From this we
conclude that the observed heterogenous responsiveness is not
a specific attribute of HUVEC but rather a common response
of endothelial cells exposed to LPS. Of notice, HMVEC-
L displayed a different composition of EC subpopulations,
which could be attributed to a specific lung-microvascular
phenotypical characteristic to support dedicated biological
functions in the lungs. The E-sel+/VCAM-1+ subpopulation
also expressed the highest levels of inflammatory mediators
IL-6, IL-8, MCP-1, CXCL6, and CXCL10, implying that this
subpopulation has a more generalized higher activation status
than the other three subpopulations. This finding is in line
with a previous study that showed that high IL-8-secreting
EC produced higher levels of endothelial adhesion molecules,
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chemokines, and cytokines compared to their low IL-8-
secreting EC counterparts (24). Why CXCL6, a chemoattractant
for neutrophils, was specifically expressed in the VCAM-1+
subpopulation remains to be clarified. Follow up studies will
determine the full nature and extent of activation of the cells in
these subpopulations.
Intriguingly, we found a subpopulation of EC that did not
express E-selectin or VCAM-1 despite prolonged exposure to
LPS. Gene expression analysis of this sorted subpopulation
of cells showed that these cells had a broader “quiescent”
phenotype since they also did not express inflammatory cytokines
and chemokines upon LPS exposure. One possible explanation
for these findings could have been that these cells lack LPS-
signaling machinery, but we showed that that was not the
case as this population was expressing both TLR4 and RIG-
I, two of the main LPS-signaling molecules in endothelial
cells. Another explanation for these findings might have been
that the cells in the “quiescent” phenotype subpopulation were
dividing and thereby subjected to repression of NF-κB–driven
inflammation as was previously reported in HeLa cells (17).
However, we found only 7% of the total HUVEC population
to be proliferating, while the quiescent population represented
around 20% of cells. Moreover, Ki67 positive, proliferating cells
were also able to express E-selectin, which confirmed previous
observations (25, 26) and VCAM-1. Hence, cell proliferation
does not appear to be a major contributing factor leading to
the “quiescent” status of these cells. Since exaggerated and
prolonged inflammatory responses can be detrimental to cells,
a negative feedback loop mechanism exists that regulates the
magnitude and duration of inflammation (27). An example of
such is the activation of the zinc finger protein A20 which limits
inflammation downstream of the NF-κB pathway. A20 mRNA
levels were, however, comparable in all EC subpopulations (data
not shown) including the quiescent EC subpopulation which
suggests that an A20-dependent inhibitory feedback mechanism
is not controlling the quiescent status of these E-selectin−/
VCAM-1− cells. Why these cells remain quiescent despite LPS
exposure is currently unknown. We will investigate this further
since understanding the molecular mechanisms associated with
this quiescent phenotype may eventually be exploited for
therapeutic strategies to inhibit endothelial activation in the
setting of sepsis.
We explored the possibility that the heterogeneous responses
by the EC subpopulations were attributed to intrinsic cellular
differences in the functionality of the LPS signaling components.
Using siRNA-based knock down we investigated the role of
TLR4 and RIG-I in this process. While TLR4 mediated both
E-sel+ and E-sel+/VCAM-1+ subpopulation formation, RIG-I
mainly had a role in E-sel+/VCAM-1+ subpopulation formation.
Knocking down MAVS, a RIG-I adaptor protein, did not
FIGURE 7 | Proposed cellular regulatory mechanisms that control the formation of LPS-mediated EC subpopulations. Dashed lines represent pathways involved in
transcriptional control of pro-inflammatory molecules, and solid lines represent pro-inflammatory proteins on EC. The blue, black, and brown lines represent
intracellular signaling pathways that determine E-sel+, E-sel+/VCAM-1+, and VCAM-1+ subpopulation formation.
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affect the formation of E-sel+ and VCAM-1+ subpopulations.
Pharmacological inhibition studies showed that NF-κB and p38
MAPK were the predominant controlling pathways for the
formation of the E-sel+ and E-sel+/VCAM-1+ subpopulations
(see Figure 7). The fact that the VCAM-1+ population at
early time points of LPS stimulation was not affected by
any of the pathways investigated raises the question how this
subpopulation is being formedwhen endothelial cells are exposed
to LPS. One way to establish a clear role of LPS signaling
in VCAM-1+ subpopulation formation is by performing
knockdown experiments and examining the activation status
when the VCAM-1+ subpopulation is at its peak (16 h after
LPS stimulation, Supplementary Figure 2B). At 16 h of LPS
exposure, it is highly likely that secondary or tertiary responses
have become part of the equation following the release of
pro-inflammatory cytokines, such as IL-6 and IL-8. Exposing
naïve HUVEC to cytokines (e.g., IL-6) has been shown to
increase E-selectin, VCAM-1, and ICAM-1 (28). Considering
the pharmacological importance of the findings reported here,
we will investigate this issue in more detail in HUVEC
subpopulations using kinase activity platform technology.
In conclusion, renal endothelial cells exert a heterogeneous
pattern of E-selectin and VCAM-1 expression following
LPS challenge, in different as well as within the same
microvascular segments. Such a heterogeneous response
was recapitulated in vitro when HUVEC and human lung
microvascular endothelial cells were exposed to LPS. The
here identified and described endothelial subpopulations
have distinct inflammatory phenotypes and are regulated by
different signaling mechanisms. At this point, it is not known
whether signaling differences contributing to the heterogeneous
expression of E-selectin and VCAM-1 has biological relevance,
nor what the pharmacological ramifications are. Such biological
relevance should be investigated in in vivo settings, as the
molecular signatures of endothelial cells differ depending
on their specialized functions and microenvironment both
in homeostasis and during inflammatory responses (21, 29).
Follow up studies will aim to further investigate the underlying
molecular pathways in in vitro and in vivo as a lead for
future therapy choices to attenuate activation of microvascular
endothelial cells in the organs of critically ill patients with sepsis.
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